Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

For superficial skin cancers, Mohs surgery can be a definitive procedure, but nonsurgical approaches are competitive in the ...

In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...

Real Housewives of Beverly Hills alum Teddi Mellencamp shared more bad news amid her ongoing battle with cancer as doctors found new tumors that are Stage 4.

Phase 2 trial results support further development of neoadjuvant nivolumab-based CIT and adaptive de-escalation of CRT in patients with locoregionally advanced HNSCC, according to researchers.

Immune checkpoint inhibitor therapy for any cancer was associated with a significant reduction of actinic keratoses, ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with ...

The supervisory board of the Company has reviewed the financial statements 2024 on April 2nd, 2025 and the Company's ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a key milestone in its ACESOT-1051 clinical trial, as the first patient with HPV-positive (HPV+) head and neck squamous cell ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...